| Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami. | |
| | |
MedLine Citation:
|
PMID: 3485168 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Corticotrophin releasing factor-like immunoreactivity (CRF-LI) and bioactivity, and arginine vasopressin-like immunoreactivity (AVP-LI) have been measured in extracts of human fetal and adult hypothalamic tissue and their development with the gestational age of the fetuses (12-27 weeks) studied. CRF-LI was measured by a radioimmunoassay developed for ovine corticotrophin-releasing factor (oCRF-41). Corticotrophin-releasing factor bioactivity was measured in a rat isolated anterior pituitary cell perfusion system. CRF-LI and bioactivity and AVP-LI were all detectable in fetal hypothalamic extracts from 12 to 13 weeks of gestational age. CRF-LI was also present in human fetal pituitary glands from 12 weeks of gestational age. The concentration of CRF-LI in the fetal hypothalamic extracts (9.2 +/- 11.4 ng/g, mean +/- S.E.M., n = 33) showed no significant correlation with the gestational age of the fetuses. However the concentration of AVP-LI (25.0-36.8 ng/g, n = 17) did show a positive correlation (r = 0.508, P less than 0.05) with gestational age, as did the concentration of CRF bioactivity (471.3-556.3 ng ACTH released/g tissue, n = 13, r = 0.725, P less than 0.01). The CRF bioactivity of all fetal hypothalamic extracts was potentiated by the addition of synthetic human (h)AVP, but the bioactivity of the adult hypothalamic extracts was not, presumably because of the higher levels of AVP-LI already present in the adult extracts. Pretreatment of tissue extracts with antisera to oCRF-41 and/or hAVP reduced the CRF bioactivity of all hypothalamic extracts. Sephadex chromatography of fractions which co-eluted with synthetic oCRF-41 or hAVP contained CRF bioactivity and this bioactivity was potentiated when synthetic hAVP or oCRF-41, respectively, were added to the fractions. However, a larger molecular weight form of CRF-LI (8000-10 000 daltons), which was observed only in fetuses of 20 weeks of gestational age or less, did not contain any significant CRF bioactivity. |
| | |
Authors:
|
J F Ackland; S J Ratter; G L Bourne; L H Rees |
Related Documents
:
|
6094048 - Acute dopaminergic blockade by sulpiride stimulates beta-endorphin secretion in pregnan... 16585958 - Ontogeny of adrenal steroid biosynthesis: why girls will be girls. 6700888 - Adrenal hypofunction and trisomy 18. 21928228 - Acute kidney injury in pregnancy: a clinical challenge. 7189728 - Estimation of pregnancy duration by means of ultrasonic measurements of the fetal crown... 7155028 - Successful treatment of male infertility caused by antispermatozoal antibodies. |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Journal of endocrinology Volume: 108 ISSN: 0022-0795 ISO Abbreviation: J. Endocrinol. Publication Date: 1986 Feb |
Date Detail:
|
Created Date: 1986-03-28 Completed Date: 1986-03-28 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0375363 Medline TA: J Endocrinol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 171-80 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arginine Vasopressin
/
metabolism Chromatography, Gel Corticotropin-Releasing Hormone / metabolism* Gestational Age Humans Hypothalamus / embryology, metabolism* Peptides / metabolism Perfusion Pituitary Gland, Anterior / cytology, metabolism Radioimmunoassay |
| Chemical | |
Reg. No./Substance:
|
0/Peptides; 113-79-1/Arginine Vasopressin; 9015-71-8/Corticotropin-Releasing Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Characterization of a colony-stimulating factor produced by the human monocytic leukemia cell line, ...
Next Document: Sex difference in the cytosolic and nuclear distribution of androgen receptor in mouse submandibular...